BELLO, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.169
AS - Asia 3.881
EU - Europa 3.352
AF - Africa 1.176
SA - Sud America 969
OC - Oceania 131
Continente sconosciuto - Info sul continente non disponibili 56
Totale 17.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.594
SG - Singapore 1.358
IT - Italia 934
CN - Cina 628
BR - Brasile 581
HK - Hong Kong 569
DE - Germania 240
FI - Finlandia 221
PL - Polonia 195
SE - Svezia 184
GB - Regno Unito 161
VN - Vietnam 155
NL - Olanda 144
FR - Francia 137
RU - Federazione Russa 104
IN - India 83
AT - Austria 71
TR - Turchia 71
AR - Argentina 68
MX - Messico 63
UA - Ucraina 63
JP - Giappone 62
BJ - Benin 57
EC - Ecuador 56
ID - Indonesia 53
IE - Irlanda 52
ES - Italia 50
KR - Corea 48
ZA - Sudafrica 45
ML - Mali 44
MA - Marocco 43
NO - Norvegia 43
BA - Bosnia-Erzegovina 42
CA - Canada 42
AL - Albania 41
CH - Svizzera 41
IQ - Iraq 41
NP - Nepal 41
GR - Grecia 40
LV - Lettonia 40
CI - Costa d'Avorio 39
PS - Palestinian Territory 39
CZ - Repubblica Ceca 38
PH - Filippine 37
PY - Paraguay 37
SA - Arabia Saudita 37
GF - Guiana Francese 36
UZ - Uzbekistan 36
VE - Venezuela 36
AO - Angola 35
CO - Colombia 35
CV - Capo Verde 35
DK - Danimarca 35
DZ - Algeria 35
AE - Emirati Arabi Uniti 34
CU - Cuba 34
GH - Ghana 34
GT - Guatemala 34
HR - Croazia 34
NC - Nuova Caledonia 34
TN - Tunisia 34
BO - Bolivia 33
CY - Cipro 33
IL - Israele 33
SN - Senegal 33
TT - Trinidad e Tobago 33
BE - Belgio 32
EE - Estonia 32
LA - Repubblica Popolare Democratica del Laos 32
PE - Perù 32
RS - Serbia 32
UG - Uganda 32
BY - Bielorussia 31
CW - ???statistics.table.value.countryCode.CW??? 31
EG - Egitto 31
HU - Ungheria 31
KZ - Kazakistan 31
LB - Libano 31
LU - Lussemburgo 31
MY - Malesia 31
NE - Niger 31
AZ - Azerbaigian 30
BB - Barbados 30
CL - Cile 30
DO - Repubblica Dominicana 30
JO - Giordania 30
MR - Mauritania 30
MZ - Mozambico 30
AU - Australia 29
HN - Honduras 29
MN - Mongolia 29
MU - Mauritius 29
SI - Slovenia 29
ZW - Zimbabwe 29
BG - Bulgaria 28
KH - Cambogia 28
NZ - Nuova Zelanda 28
RE - Reunion 28
BS - Bahamas 27
BZ - Belize 27
Totale 16.439
Salva come PNG Salva come JPEG
Città #
Fairfield 1.100
Ashburn 847
Singapore 803
Woodbridge 654
Hong Kong 546
Houston 523
Ann Arbor 470
Chandler 461
Seattle 399
Cambridge 362
Wilmington 331
Beijing 234
Boardman 201
Santa Clara 156
San Diego 150
Padova 139
Bytom 137
Princeton 120
Medford 110
Los Angeles 96
Milan 96
Roxbury 92
Munich 91
New York 88
Des Moines 86
Helsinki 77
Jacksonville 73
Cotonou 55
Hefei 53
Nuremberg 52
Chicago 51
Rome 49
São Paulo 45
Ho Chi Minh City 43
Vienna 43
Bamako 40
Turku 39
Dublin 38
Riga 38
Abidjan 37
Nanjing 37
London 36
Noumea 34
Dakar 33
Lappeenranta 33
Buffalo 32
Havana 31
Tashkent 31
Amman 30
Kampala 30
Tokyo 30
Warsaw 30
Luanda 29
Nouakchott 29
Vientiane 28
Baku 27
Nassau 27
Praia 27
Accra 26
Bridgetown 26
Ulan Bator 26
Conakry 25
Harare 25
Libreville 25
Lusaka 25
Redondo Beach 25
Seoul 25
Tallinn 25
Willemstad 25
Bishkek 24
Dushanbe 24
Guatemala City 24
Niamey 24
Phnom Penh 24
Rio de Janeiro 24
Djibouti 23
Hanoi 23
Istanbul 23
Maputo 23
Panama City 23
Podgorica 23
Tirana 23
Antananarivo 22
Athens 22
Johannesburg 22
Luxembourg 22
Minsk 22
Nairobi 22
Andorra la Vella 21
Cairo 21
Lima 21
Managua 21
Montevideo 21
Cayenne 20
Dong Ket 20
Reykjavik 20
San José 20
Auckland 19
Castries 19
Chisinau 19
Totale 10.536
Salva come PNG Salva come JPEG
Nome #
Molecular bases of phenotypic and clinical variability in Duchenne and Becker muscular dystrophy 498
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 280
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 242
Parkinson-like features in ALS with predominant upper motor neuron involvement 207
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 204
Muscle MRI and functional outcome measures in Becker muscular dystrophy 203
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 199
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 198
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 196
Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trials 191
Ablation of collagen VI leads to the release of platelets with altered function 187
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 186
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 185
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 176
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 170
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 168
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 168
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 167
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 166
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 163
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 163
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. 162
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy 159
Reliability of the North Star Ambulatory Assessment in a multicentric setting 158
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 158
“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy 156
The clinical spectrum of CASQ1-related myopathy 152
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 150
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 149
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up 149
Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations 148
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 147
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 146
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 146
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 144
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 143
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 143
Evaluation of peripherin in biofluids of patients with motor neuron diseases 143
Dystrophinopathies 141
Redefining phenotypes associated with mitochondrial DNA single deletion 141
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy 141
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 140
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 140
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. 139
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 137
OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages 137
Revisiting mitochondrial ocular myopathies: a study from the Italian Network 137
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 136
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E 136
Molecular bases of phenotypic and clinical variability in Duchenne and Becker muscular dystrophy 135
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study 132
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 132
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 129
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy 129
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis 128
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 128
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen 126
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction 125
European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A) 123
PROCEEDINGS OF THE XXI CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: Digital EditionDecember 01-04, 2021 Neurofilament light chain and Profilin-1 in adult SMA patients under nusinersen treatment: 26-months follow-up 123
Interpreting genetic variants in titin in patients with muscle disorders 122
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study 121
Functional changes in Duchenne muscular dystrophy A 12-month longitudinal cohort study 120
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study 120
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 118
Muscle MR Imaging in Tubular Aggregate Myopathy. 117
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 117
Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy 116
Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III 115
Assessment of disease progression in dysferlinopathy: A 1-year cohort study 115
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients 114
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 114
Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy 114
Genetic modifiers of muscle: Studies of college students and Duchenne muscular dystrophy 112
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 112
The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy 111
The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA) 109
The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy 108
Cognitive profile in LGMD-2I 107
Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells 106
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy 106
Large scale networks for human hand-object interaction: Functionally distinct roles for two premotor regions identified intraoperatively 106
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis. 104
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 103
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale 103
Whole-body muscle MRI in McArdle disease 103
A Mutation in the CASQ1 Gene Causes a Vacuolar Myopathy with Accumulation of Sarcoplasmic Reticulum Protein Aggregates. 102
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 101
DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions 100
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges 97
The relevance of migraine in the clinical spectrum of mitochondrial disorders 97
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 96
Neurofilament light chain and profilin-1 dynamics in 30 spinalmuscular atrophy type 3 patients treated with nusinersen 96
Nerve ultrasound in CANVAS‐spectrum disease: Reduced nerve size distinguishes genetically confirmed CANVAS from other axonal polyneuropathies 95
Influence of β2 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy 95
Caregiver psychological profile and perceived quality of life in children affected by Duchenne Muscular Dystrophy 93
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 93
226thENMC International Workshop:. Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands 91
Genome-Wide Association Studies in Muscle Physiology and Disease 91
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 91
Totale 14.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.001
article - articoli 52.539
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 679
Totale 111.219
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 71 58 42 132 144 165 165 83
2021/20221.758 180 174 225 112 64 121 115 158 54 57 150 348
2022/20231.026 222 69 28 116 177 144 7 73 105 25 46 14
2023/2024836 16 70 83 65 60 93 83 57 52 60 97 100
2024/20253.573 43 168 171 143 401 129 236 287 292 206 584 913
2025/20266.747 668 1.140 2.178 2.532 229 0 0 0 0 0 0 0
Totale 18.040